amiloride has been researched along with Pneumonia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Folkesson, HG; Kuzenko, SR; Lipson, DA; Matthay, MA; Simmons, MA | 1 |
App, EM; Helfesrieder, R; King, M; Köhler, D; Matthys, H | 1 |
1 trial(s) available for amiloride and Pneumonia
Article | Year |
---|---|
Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
Topics: Administration, Inhalation; Adolescent; Adult; Age Factors; Amiloride; Child; Cough; Cystic Fibrosis; Elasticity; Electrolytes; Female; Humans; Lung Diseases; Male; Mucociliary Clearance; Pneumonia; Random Allocation; Respiratory Function Tests; Sputum; Viscosity | 1990 |
1 other study(ies) available for amiloride and Pneumonia
Article | Year |
---|---|
The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats.
Topics: Acute Lung Injury; Adenosine; Amiloride; Animals; Biological Transport; Bronchoalveolar Lavage; Cystic Fibrosis Transmembrane Conductance Regulator; Endotoxemia; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Escherichia coli; Escherichia coli Infections; Immunoblotting; Male; Pneumonia; Pulmonary Alveoli; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Respiratory Physiological Phenomena; Sodium Channel Blockers; Triazoles | 2012 |